Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 571 | 237 | 730 | 11,202 | -1 |
| Gross Profit | 571 | 237 | 730 | 11,202 | -1 |
| Operating Expenses | 14,809 | 12,902 | 11,136 | 11,783 | 5,336 |
| Operating Income | -14,238 | -12,665 | -10,406 | -581 | -5,337 |
| Interest Expense | 789 | 1,367 | 1,666 | 1,016 | 0 |
| Other Income | -817 | 7 | -2,531 | -22 | 493 |
| Pre-tax Income | -15,844 | -14,025 | -14,603 | -1,619 | -4,844 |
| Net Income Continuous | -15,864 | -14,025 | -14,603 | -1,619 | -5,056 |
| Net Income | $-15,864 | $-14,025 | $-14,603 | $-1,619 | $-5,056 |
| EPS Basic Total Ops | -1.40 | -1.17 | -1.22 | -0.15 | -0.47 |
| EPS Basic Continuous Ops | -1.40 | -1.17 | -1.22 | -0.15 | -0.47 |
| EPS Diluted Total Ops | -1.40 | -1.17 | -1.22 | -0.15 | -0.47 |
| EPS Diluted Continuous Ops | -1.40 | -1.17 | -1.22 | -0.15 | -0.47 |
| EBITDA(a) | $-14,226 | $-12,654 | $-10,437 | $-528 | $-5,549 |